Moreover, the molecular mechanisms underlying the oncogenic functions of XPO1 and exportin family members in ccRCC have not been fully elucidated, hindering the development of effective targeted therapies. This evidence concerns the gene XPO1 and nonpapillary renal cell carcinoma.